Clinical Trial Update: StrataGraft® Skin Tissue Expanded Access at Specific Study Sites ( StrataCAT ) [Phase 3]

View source ↗

Summary

Phase 3 trial update for StrataGraft with expanded access at specific study sites (StrataCAT) for deep partial-thickness burns; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Partial-thickness Burn

Drugs mentioned

• StrataGraft

Snippet

Sponsor: Stratatech, a Mallinckrodt Company | Conditions: Deep Partial-thickness Burn | Phase 3 | Status: COMPLETED | Results posted: 2023-11-09